The 6A™ Strategic Landscape
Too many therapies stall because the diagnostic strategy wasn’t nailed early enough. The 6A™ Strategic Landscape fixes that. It’s built to help you sidestep six friction points to testing success: Awareness, Adoption, Access, Availability, Accuracy, and Action. The 6A™ Strategic Landscape gives you a clear line of sight across the diagnostic landscape - what’s working, what’s holding you back, and where to focus.
6A™ Strategic Landscape
Success starts with a smarter plan
Powered by data, validated by experts
Our AI-powered framework prioritizes the right data combined with our precision medicine expertise to validate these findings, and provide strategic recommendations - turning intelligence into execution.
Real-world insight, not retrospective theory
Insights powered by data from over 2,500+ labs across 50+ countries, leveraging Diaceutics’ multi-modal dataset - including diagnostic, claims, treatment, and lab behavior data.
A biomarker testing lens on drug commercialization
The 6A™ Strategic Landscape maps testing realities to therapy performance, highlighting how the biomarker test and field execution shape success.
When the plan isn’t precise, adoption falters
Whether you’re planning a market entry or trying to course-correct, the 6A™ framework gives you the clarity to act decisively - boosting patient identification, aligning diagnostic and therapy uptake, and making every investment count.
It ensures your brand strategy includes a sharp, structured view of the most critical focus areas influencing biomarker test adoption, so you can prioritize the right moves, deploy resources with confidence, and accelerate test uptake before launch even begins.
The 6A™ Strategic Landscape enables your team to:
• Highlight the most critical focus areas influencing testing success - so you can act early, align strategy, and maximize impact before launch.
• Get clarity on where testing is happening, who’s doing it, and where your engagement is falling short - so you can stop spreading efforts thin and start targeting what matters.
• Bring commercial, diagnostic, medical, and market access teams together around a shared view of what needs to happen - and when - to drive testing success.
• Access a data-driven diagnostic risk assessment and mitigation plan - identifying gaps, mapping strategies, and demonstrating that your therapy’s testing approach is fit for market.
• Spot and fix gaps in the testing and treatment pathway early - so you maximize identification and uptake from day one.
Turn blind spots into confident execution with the 6A™ Strategic Landscape
Source: Data insights sourced from Diaceutics’ client projects.
Insights from 2500+ Labs across 50+ countries identified fast adopters with accurate testing capabilities and flagged country-specific logistical and reimbursement barriers early.
The 6A™ Landscape identified all key stakeholders involved in the test journey including those often missed in traditional planning, enabling targeted education that improved test result actionability and drove therapy adoption.
Brands using the 6A™ Landscape have accelerated test readiness timelines by 6-8 months on average, compared to traditional market readiness planning cycles.
Resources
Discover more about 6A™ Precision Medicine Strategic Landscape by clicking into the resources below:
Webinar
Illuminate hidden barriers and highlight opportunities for commercial success
Ensure your existing strategy is precision medicine ready and build tactical strategies rooted in real world actionable insights with The 6A™ Strategic Landscape. Discover more in our recent webinar.
Case Study
Drive strategic diagnostic planning for targeted therapy
Learn how a top 10 global pharma company tackled the challenge of launching a precision medicine therapy for a gender-specific cancer. Find out how their strategy accelerated adoption and improved patient access.